Neuropathic pain drugs linked to higher hip fracture risk in seniors
A new study by Monash University medicine safety experts found the use of gabapentinoids—medicines widely used to treat ...
Science Daily3d
Neuropathic pain drugs found to increase risk of hip fracture in older adults
A new study by medicine safety experts found the use of gabapentinoids -- medicines widely used to treat neuropathic pain -- increased the risk of hip fractures, especially in older patients who were ...
Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain
Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...
Medscape1d
New Approaches to the Pharmacotherapy of Neuropathic Pain
On the other hand, one symptom, cold allodynia for example, can be the result of various mechanisms in peripheral or central neuropathic pain. [25] Another point that is important to discuss is ...
The Victoria Advocate11d
Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain
The trial investigates the efficacy, safety and tolerability of QUTENZA ® (capsaicin) 8% topical system in post-surgical neuropathic pain (PSNP) and if successful could support an extension of ...
MIRA Pharmaceuticals' Formulated Shows Greater Efficacy Than FDA-Approved Drug For Chemo-Induced Neuropathic Pain
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) stock is trading higher on Monday after the company released new preclinical ...
Promising Developments and Strategic Focus Bolster Buy Rating for Rapport Therapeutics
JonesTrading analyst Justin Walsh has reiterated their bullish stance on RAPP stock, giving a Buy rating on November 7. Justin Walsh’s ...
Prediction: This Biotech Stock Is Heading for a Once-in-a-Generation Opportunity
Vertex has reached a key moment because the U.S. Food and Drug Administration (FDA) is reviewing its candidate, suzetrigine, ...
FierceBiotech10d
Rapport's attempt to test epilepsy drug in nerve damage placed on hold by FDA
The FDA has placed a trial of Rapport Therapeutics’ epilepsy drug for a type of nerve pain on hold while the biotech tweaks ...
Coachella Valley heroes honored at 18th annual National Philanthropy Day Awards
"This has been an exceptional year with countless acts of remarkable philanthropy in our valley," said AFP board president ...
Benzinga.com20d
MIRA Pharmaceuticals' Formulated Shows Greater Efficacy Than FDA-Approved Drug For Chemo-Induced Neuropathic Pain
The new preclinical data show that Ketamir-2 is 60% more effective than the FDA-approved neuropathic pain treatment gabapentin in reducing chemotherapy-induced pain. The study used the paclitaxel ...